HonorHealth Cancer Care - Biltmore
2222 E. Highland Ave. Ste. 400
Phoenix, AZ 85016
Lyndsay Willmott, MD
Gynecologic Oncology
Languages: English
HonorHealth Medical Staff Member
Call 602-277-4868
Insurance accepted
Insurance Plans
- AHCCCS Complete Care.
- AHCCCS CRS
- Dual-SNP
- 3 Tier Plans
- Banner Employees - Tier 2
- HMO
- PPO
- EPO
- Ameriben
- POS
- Indemnity
- CHS
- Alliance Network
- FEP (Standard, Basic and Blue Focus),
- Workers' Comp
- EverydayHealth PPO,
- BluePathway Plan 2 - Medicare Advantage
- BluePathway Plan 3 - - Medicare Advantage
- BlueJourney PPO - Medicare Advantage
- Classic/Plus - Medicare Advantage
- Medisun - Medicare Advantage
- All
- HMO
- PPO
- PPO Plus
- POS
- EPO
- LocalPlus
- Open Access Plan (OAP)
- CignaChoice Fund Access Plus
- Open Access Plus
- PPO
- RAN
- PPO
HonorHealth accepts most health insurance plans at its hospitals and physician offices. However, you need to contact your health insurance company to verify your coverage for individual physicians/providers and their physicians before you seek services.
Specialties
- Gynecologic Oncology
Credentials
-
Residency
Strong Memorial Hospital of the University of Roch -
Education
The State University Of New York College At Buffalo -
Fellowship
University of California, Irvine, School of Medicine -
Board Certifications
American Board of Obstetrics and Gynecology - Gynecologic Oncology, American Board of Obstetrics and Gynecology - Obstetrics and Gynecology
About
HonorHealth Cancer Care gives you access to an elite team of experts across the Valley. The physicians we collaborate with are nationally and internationally recognized.
Dr. Willmott's driving force for the ftreatment of women with cancer is to empower her patients through their journey. She understands the fimportance of maintaining quality of life and educating her patients on all resources available. She treats all gynecologic cancers including ovarian, uterine, cervical and vulvar cancer. She also serves as principal investigator on a number of clinical trials, granting patients access to the latest clinical research and treatment.